Vineet Agarwal

Plus aucun poste en cours

Fortune : - $ au 31/05/2024

Finance

Consumer Services

Health Technology

Postes actifs de Vineet Agarwal

Sociétés	Poste	Début	Fin
Korro Bio, Inc. Korro Bio, Inc. BiotechnologyHealth Technology Korro Bio, Inc. engages in the development of a bio therapeutics. It focuses on a proprietary platform designed to selectively edit messenger RNA and recode specific codons to effect changes in protein structure and function across multiple tissues. The company was founded by Jean-Fran?ois Formela, Josh Rosenthal, Nessan Bermingham, and Andrew Fraley in 2018 and is headquartered in Cambridge, MA.	Directeur Financier/CFO	01/05/2021	-

Sociétés	Poste	Début	Fin
09143628 Ltd.	Corporate Officer/Principal	01/01/2016	01/05/2021
JPMORGAN CHASE & CO.	Directeur/Membre du Conseil	01/01/2019	01/05/2021
JPMORGAN CHASE & CO.	Corporate Officer/Principal	01/01/2016	01/01/2019

Institute of Management Technology	Masters Business Admin
Shri Ram College of Commerce	Undergraduate Degree

Internationale

Opérationnelle

Director of Finance/CFO	2
Corporate Officer/Principal	2
Comptroller/Controller/Auditor	1

Sectorielle

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés cotées	1
JPMORGAN CHASE & CO.	Finance

Entreprise privées	2
Korro Bio, Inc. Korro Bio, Inc. BiotechnologyHealth Technology Korro Bio, Inc. engages in the development of a bio therapeutics. It focuses on a proprietary platform designed to selectively edit messenger RNA and recode specific codons to effect changes in protein structure and function across multiple tissues. The company was founded by Jean-Fran?ois Formela, Josh Rosenthal, Nessan Bermingham, and Andrew Fraley in 2018 and is headquartered in Cambridge, MA.	Health Technology
09143628 Ltd.	Finance

Entreprise privées

Health Technology

09143628 Ltd.

Finance